Make an
impact today

When you choose to give, you become part of something bigger—something powerful.

Endometrial Cancer Research at Penn Medicine:

Advancing Endometrial Cancer Research

Endometrial cancer is the most common gynecologic cancer in the United States, affecting thousands of women and families each year. The goal of endometrial cancer research is to improve prevention, early detection, diagnosis, treatment, and survivorship outcomes for those impacted by the disease.

Researchers work to better understand the genetic, molecular, hormonal, and environmental factors that contribute to the development and progression of endometrial cancer. Through scientific discovery and clinical innovation, research helps identify new biomarkers for earlier detection, develop more effective and personalized treatments, and reduce the side effects associated with current therapies.

Endometrial cancer research also seeks to address disparities in outcomes among different populations, ensuring that advances in care benefit all patients. By supporting laboratory studies, clinical trials, and translational research, scientists can transform promising discoveries into real-world treatments that improve quality of life and increase survival rates.

Every breakthrough brings us closer to a future where endometrial cancer can be detected earlier, treated more effectively, and ultimately prevented. Investment in research offers hope to patients, families, and future generations by driving innovation and accelerating progress toward better outcomes for all.

“We achieve this goal of advancing care for endometrial cancer through the development of humanized models for experimentation.”

Make a Donation

When you choose to give, you become part of something bigger—something powerful. Your support fuels progress and brings hope where it's needed most.

3% Cover the Fee

Frequently Asked Questions